HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis of 1-beta-D-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus.

Abstract
There are no FDA approved drugs for the treatment of hemorrhagic fever with renal syndrome (HFRS), a serious human illnesses caused by hantaviruses. Clinical studies using ribavirin (RBV) to treat HFRS patients suggest that it provides an improved prognosis when given early in the course of disease. Given the unique antiviral activity of RBV and the lack of other lead scaffolds, we prepared a diverse series of 3-substituted 1,2,4-triazole-beta-ribosides and identified one with antiviral activity, 1-beta-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR). ETAR showed an EC(50) value of 10 and 4.4 microM for Hantaan virus (HTNV) and Andes virus, respectively. ETAR had weak activity against Crimean Congo hemorrhagic fever virus, but had no activity against Rift Valley fever virus. Intraperitoneally delivered ETAR offered protection to suckling mice challenged with HTNV with a approximately 25% survival at 12.5 and 25mg/kg ETAR, and a MTD of 17.1+/-0.7 days. ETAR was phosphorylated in Vero E6 cells to its 5'-triphosphate and reduced cellular GTP levels. In contrast to RBV, ETAR did not increase mutation frequency of the HTNV genome, which suggests it has a different mechanism of action than RBV. ETAR is an exciting and promising lead compound that will be elaborated in further synthetic investigations as a framework for the rational design of new antivirals for treatment of HFRS.
AuthorsDong-Hoon Chung, Sidath C Kumarapperuma, Yanjie Sun, Qianjun Li, Yong-Kyu Chu, Jeffrey B Arterburn, William B Parker, Jeffrey Smith, Kristin Spik, Harish N Ramanathan, Connie S Schmaljohn, Colleen B Jonsson
JournalAntiviral research (Antiviral Res) Vol. 79 Issue 1 Pg. 19-27 (Jul 2008) ISSN: 0166-3542 [Print] Netherlands
PMID18394724 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • 1-ribofuranosyl-3-ethynyl-(1,2,4)triazole
  • Antiviral Agents
  • Nucleosides
  • Triazoles
  • Guanosine
  • Ribavirin
  • Guanosine Triphosphate
Topics
  • Animals
  • Antiviral Agents (chemical synthesis, metabolism, pharmacology)
  • Chlorocebus aethiops
  • Female
  • Genome, Viral (drug effects)
  • Guanosine (antagonists & inhibitors, metabolism)
  • Guanosine Triphosphate (antagonists & inhibitors, metabolism)
  • Orthohantavirus (drug effects, genetics, metabolism)
  • Hemorrhagic Fever with Renal Syndrome (drug therapy, virology)
  • Humans
  • Mice
  • Mice, Inbred Strains
  • Mutation (drug effects)
  • Nucleosides (chemical synthesis, metabolism, pharmacology)
  • Ribavirin (analogs & derivatives, chemical synthesis, metabolism, pharmacology)
  • Triazoles (chemical synthesis, metabolism, pharmacology)
  • Vero Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: